Executive Committee (ExCo) meeting of 11 September 2025, WADA wishes to update stakeholders regarding the ExCo’s decision to ...
The World Anti-Doping Agency (WADA) would like to remind stakeholders to register now for the Agency’s sixth World Conference ...
Commencing 26 September, the President of the World Anti-Doping Agency (WADA), Witold Bańka, was in Africa to engage with a ...
WADA announces candidates for 2026 National Anti-Doping Organization Expert Advisory Group elections
Elections to be held in October The World Anti-Doping Agency (WADA) is pleased to announce the candidates for the upcoming ...
The sport organizations within the following categories have accepted the Code. An International Federation marked with * is also an ASOIF associate-members. International Federations marked with ⁰ ...
The International Standard for Therapeutic Use Exemptions (ISTUE) is a mandatory International Standard developed as part of the World Anti-Doping Program. The purpose of the ISTUE is to establish the ...
WADA annually publishes statistical reports as reported by the WADA-accredited laboratories in ADAMS. Previous testing figures reports can currently be found under Archives.
This paper discusses glucocorticoid (GC) use in athletes and the general requirements of a Therapeutic Use Exemption (TUE). You can subscribe to notifications about TUE-related resources by clicking ...
The fundamental principle of the Athlete Biological Passport (ABP) is to monitor selected biological variables over time that indirectly reveal the effects of doping, rather than attempting to detect ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback